MHB018A

· Minghui Pharmaceutical (Hangzhou) Ltd

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MHB018A, covering 2026-03-30 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: MHB018A Treatment in Patients With Active Thyroid Eye Disease [Phase 3]